Niederer Kraft Frey advises Athagoras on financing for acquisitions
Niederer Kraft Frey advised German biotech & pharma consultant Athagoras on the financing process within the acquisitions of CSO and MigX.
The parties involved
Athagoras is a technology-enabled platform for life sciences that supports pharma, biotech and medtech companies in achieving fast and efficient access to their core markets. Its services also spans regulatory affair and pharmacovigilance. The company is part of a larger portfolio held by Greenpeak , a Dutch “buy and build” firm specialised in the creation of platforms for sustainable growth.
CSO advises pharmaceutical companies and healthcare providers all across the fields of pharmacovigilance, medical affairs, quality management & GDP and development consulting. Moreover, Its customers have access to an audited pharmacovigilance system, which positions CSO as an ideal dedicated outsourcing partner.
MigX ‘s expertise as life-science service provider lies in the areas of data integration and AI. Once a small tech startup, the company has been substantially growing its operative reach over the past few years.
The team
Transaction partner Philip Spoerlé (pictured) led the NFK team, with the additional support of associates Selim Lötscher and Lorenzo Henseler (all transactions). Partner Markus Kronauer handled all taxation matters.
German law firm Goodwin LLP was the lead counsel for the transaction, with partner Winfried M. Carli and associates Rebecca Stöcklein and Marius Garnatz (private equity/finance) forming the team.